Alphina Therapeutics
Alphina Therapeutics is a New Haven, Connecticut precision-oncology biotechnology company founded by experts in DNA repair and metabolic lethality. It develops next-generation antibody-drug conjugates (ADCs) that deliver potent NAMPT inhibitor payloads directly to tumors, designed to kill both dividing and non-dividing cancer cells, and pairs them with a proprietary companion diagnostic that identifies the patients most likely to respond. The company is venture-backed by Canaan Partners. It was surfaced as a portfolio company and added to the API Evangelist network as a stub; it publishes no public developer program, API, SDK, or documentation, so no API artifacts apply at this time.
Alphina Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Oncology, Therapeutics, and Antibody-Drug Conjugates.
Alphina Therapeutics’ developer surface includes engineering blog and 3 more developer resources.
Kin Score
Resources
Company 4
The organization behind the API